Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study
- PMID: 23300807
- PMCID: PMC3531337
- DOI: 10.1371/journal.pone.0052893
Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study
Abstract
Background: Placenta accreta/increta/percreta is associated with major pregnancy complications and is thought to be becoming more common. The aims of this study were to estimate the incidence of placenta accreta/increta/percreta in the UK and to investigate and quantify the associated risk factors.
Methods: A national case-control study using the UK Obstetric Surveillance System was undertaken, including 134 women diagnosed with placenta accreta/increta/percreta between May 2010 and April 2011 and 256 control women.
Results: The estimated incidence of placenta accreta/increta/percreta was 1.7 per 10,000 maternities overall; 577 per 10,000 in women with both a previous caesarean delivery and placenta praevia. Women who had a previous caesarean delivery (adjusted odds ratio (aOR) 14.41, 95%CI 5.63-36.85), other previous uterine surgery (aOR 3.40, 95%CI 1.30-8.91), an IVF pregnancy (aOR 32.13, 95%CI 2.03-509.23) and placenta praevia diagnosed antepartum (aOR 65.02, 95%CI 16.58-254.96) had raised odds of having placenta accreta/increta/percreta. There was also a raised odds of placenta accreta/increta/percreta associated with older maternal age in women without a previous caesarean delivery (aOR 1.30, 95%CI 1.13-1.50 for every one year increase in age).
Conclusions: Women with both a prior caesarean delivery and placenta praevia have a high incidence of placenta accreta/increta/percreta. There is a need to maintain a high index of suspicion of abnormal placental invasion in such women and preparations for delivery should be made accordingly.
Conflict of interest statement
Figures
Similar articles
-
Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States.Am J Obstet Gynecol. 2021 Nov;225(5):534.e1-534.e38. doi: 10.1016/j.ajog.2021.04.233. Epub 2021 Apr 21. Am J Obstet Gynecol. 2021. PMID: 33894149
-
Retrospective study of placenta accreta, placenta increta and placenta percreta in Peripartum hysterectomy specimens.Indian J Pathol Microbiol. 2020 Feb;63(Supplement):S87-S90. doi: 10.4103/IJPM.IJPM_229_19. Indian J Pathol Microbiol. 2020. PMID: 32108636
-
Placenta praevia and accreta after previous caesarean section.Eur J Obstet Gynecol Reprod Biol. 1993 Dec 30;52(3):151-6. doi: 10.1016/0028-2243(93)90064-j. Eur J Obstet Gynecol Reprod Biol. 1993. PMID: 8163028
-
Placenta accreta spectrum: accreta, increta, and percreta.Obstet Gynecol Clin North Am. 2015 Jun;42(2):381-402. doi: 10.1016/j.ogc.2015.01.014. Obstet Gynecol Clin North Am. 2015. PMID: 26002174 Review.
-
Etiopathogenesis and risk factors for placental accreta spectrum disorders.Best Pract Res Clin Obstet Gynaecol. 2021 Apr;72:4-12. doi: 10.1016/j.bpobgyn.2020.07.006. Epub 2020 Jul 15. Best Pract Res Clin Obstet Gynaecol. 2021. PMID: 32753310 Review.
Cited by
-
Temporal trends in peripartum hysterectomy among individuals with a previous cesarean delivery by race/ethnicity in the United States: A population-based cohort study.PLoS One. 2024 May 31;19(5):e0304777. doi: 10.1371/journal.pone.0304777. eCollection 2024. PLoS One. 2024. PMID: 38820511 Free PMC article.
-
Obstetric and haematological management and outcomes of women with placenta accreta spectrum by planned or urgent delivery: Secondary data analysis of a public referral hospital in Lebanon.PLoS One. 2024 May 8;19(5):e0302366. doi: 10.1371/journal.pone.0302366. eCollection 2024. PLoS One. 2024. PMID: 38718031 Free PMC article.
-
Mouse Surgical Model of Mechanical Uterine Injury and Subsequent Embryo Defects.Curr Protoc. 2024 Apr;4(4):e1044. doi: 10.1002/cpz1.1044. Curr Protoc. 2024. PMID: 38666634
-
Assisted reproductive technology-associated risk factors for placenta accreta spectrum after vaginal delivery.Sci Rep. 2024 Mar 29;14(1):7454. doi: 10.1038/s41598-024-57988-x. Sci Rep. 2024. PMID: 38548810 Free PMC article.
-
Pathologic maternal and neonatal outcomes associated with programmed embryo transfer.J Assist Reprod Genet. 2024 Apr;41(4):821-842. doi: 10.1007/s10815-024-03041-9. Epub 2024 Mar 27. J Assist Reprod Genet. 2024. PMID: 38536594 Review.
References
-
- Oyelese Y, Smulian JC (2006) Placenta previa, placenta accreta, and vasa previa. Obstetrics and gynecology 107: 927–941. - PubMed
-
- Khong TY (2008) The pathology of placenta accreta, a worldwide epidemic. Journal of clinical pathology 61: 1243–1246. - PubMed
-
- Wu S, Kocherginsky M, Hibbard JU (2005) Abnormal placentation: twenty-year analysis. American journal of obstetrics and gynecology 192: 1458–1461. - PubMed
-
- Miller DA, Chollet JA, Goodwin TM (1997) Clinical risk factors for placenta previa-placenta accreta. American journal of obstetrics and gynecology 177: 210–214. - PubMed
-
- RCOG Clinical Effectiveness Support Unit (2001) The National Sentinel Caesarean Section Audit Report. London: RCOG.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous